Previous Article | Next Article 
Molecular and Cellular Biology, January 2001, p. 501-510, Vol. 21, No. 2
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.2.501-510.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
The Mechanism of Mammalian Gene Replacement Is Consistent with
the Formation of Long Regions of Heteroduplex DNA Associated with
Two Crossing-Over Events
Julang
Li,1,*
Leah R.
Read,2 and
Mark D.
Baker1,2
Department of Molecular Biology and
Genetics1 and Department of
Pathobiology,2 University of Guelph,
Guelph, Ontario, Canada N1G 2W1
Received 14 July 2000/Returned for modification 25 August
2000/Accepted 18 October 2000
 |
ABSTRACT |
In this study, the mechanism of mammalian gene replacement was
investigated. The system is based on detecting homologous recombination between transferred vector DNA and the haploid, chromosomal
immunoglobulin µ-
region in a murine hybridoma cell line. The
backbone of the gene replacement vector (pCµC
pal) consists of
pSV2neo sequences bounded on one side by homology to the µ gene
constant (Cµ) region and on the other side by homology to the
gene constant (C
) region. The Cµ and C
flanking arms of
homology were marked by insertions of an identical 30-bp palindrome
which frequently escapes mismatch repair when in heteroduplex DNA
(hDNA). As a result, intermediates bearing unrepaired hDNA generate
mixed (sectored) recombinants following DNA replication and cell
division. To monitor the presence and position of sectored sites and,
hence, hDNA formation during the recombination process, the palindrome
contained a unique NotI site that replaced an endogenous
restriction enzyme site at each marker position in the vector-borne
Cµ and C
regions. Gene replacement was studied under conditions
which permitted the efficient recovery of the product(s) of individual
recombination events. Analysis of marker segregation patterns in
independent recombinants revealed that extensive hDNA was formed within
the Cµ and C
regions. In several recombinants, palindrome markers in the Cµ and C
regions resided on opposite DNA strands
(trans configuration). These results are consistent with
the mammalian gene replacement reaction involving two crossing-over
events in homologous flanking DNA.
 |
INTRODUCTION |
The introduction of predetermined
alterations in chromosomal sequences by homologous recombination with
transferred DNA (gene targeting) is a powerful technology
for modifying gene structure and function. It has applications
that include the study of gene expression in its normal chromosomal
environment and the creation of animal models of human genetic diseases
and, ultimately, it has the potential to be an effective form of gene
therapy (3, 33, 35). In addition, the ability to
manipulate the transforming DNA makes gene targeting a valuable model
system in the study of homologous recombination mechanisms.
Gene targeting can be performed with either insertion ("ends-in" or
O-type) vectors or replacement ("ends-out" or
-type) vectors. In
an insertion vector, a double-strand break is introduced within the
homology region creating DNA ends that invade cognate chromosomal
sequences. In Saccharomyces cerevisiae, gene targeting using
an insertion vector is consistent with the double-strand-break repair
(DSBR) model (24, 32). Like yeast, targeted vector insertion in mammalian cells also has features consistent with DSBR
(16, 17, 23, 34). In a gene replacement vector, the region
of homology is interrupted by a selectable genetic marker. Since the
ends of the vector are discontinuous with the chromosome, recombination
replaces a region of the chromosome with vector sequences. The
mechanism of homologous recombination with a gene replacement vector is
unknown. In principle, it might occur by assimilation of a single
strand of the vector into the chromosome, as was proposed to explain
the replacement of a chromosomal allele with linear duplex DNA in
S. cerevisiae (15). However, single-strand assimilation might be impeded by the heterology encoded by the selectable marker. Nevertheless, Negritto et al. (21)
found at least a 10-fold increase in marker incorporation in an
msh2 mutant even when all flanking markers were identical.
Thus, marker assimilation may occur and be corrected by a process that
involves mismatch repair (MMR) genes (15, 21). Gene
replacement by single strand assimilation predicts that markers in
flanking heteroduplex DNA (hDNA) will reside in a cis
configuration. Alternatively, gene replacement might involve two
crossing-over events in the homologous DNA flanking the
selectable marker. This could explain how chromosomal deletions
are engineered in the yeast genome using replacement vectors in
which the selectable marker is flanked by two very distant homology
regions (10, 26, 31). In this instance, markers in
flanking hDNA would reside in a trans configuration. Thus,
the models make testable predictions about the configuration of hDNA in
the recombinants.
An important contribution to the study of hDNA formation during
homologous recombination came from studies in S. cerevisiae, where a small palindrome was shown to avoid MMR when
encompassed within hDNA, likely as a consequence of it forming a small
hairpin structure (20). Semiconservative DNA replication
of unrepaired hDNA, followed by cell division, generates a mixed
(sectored) recombinant. Thus, the positions of sectored sites mark the
location of hDNA formed during recombination. Earlier, we showed that a small palindrome in hDNA is also poorly repairable by the mammalian MMR
system (16), a feature that provided some important
insights into the formation of hDNA during targeted vector insertion in mammalian cells (16, 17). To obtain information about the presence and position of hDNA formed during mammalian gene replacement, we constructed a gene replacement vector in which the flanking arms of
homology were marked by insertions of the small palindrome. Among the
several independent recombinants in which hDNA was present in both
flanking arms of homology, the palindrome markers were predominantly in
a trans configuration. This result is consistent with the
mammalian gene replacement reaction involving two crossing-over events.
 |
MATERIALS AND METHODS |
Recipient hybridoma cells.
The haploid, chromosomal
immunoglobulin µ-
heavy chain locus in the wild-type murine
hybridoma cell line, Sp6/HL, serves as the target for gene replacement
(see Fig. 2). The origin of Sp6/HL and the methods used for hybridoma
cell culture have been described previously (13, 14).
Gene replacement vector.
The 13.1-kb omega (
)-form,
enhancer-trap gene replacement vector, pCµC
pal (Fig.
1) was used in these studies. The
backbone of pCµC
pal consists of a 5.4-kb segment of pSV2neo
(28) from which the 372-bp NsiI/NdeI
fragment encompassing the simian virus 40 early-region enhancer
responsible for neo gene expression was removed. To effect
gene replacement, the flanking arms of homology in pCµC
pal
consisted of a 4.2-kb Bst1107/XbaI Cµ region
fragment and a 3.5-kb SpeI/SacI C
region
fragment positioned to the left and right of pSV2neo, respectively.
Both fragments were derived from cloned, wild-type Sp6/HL genomic DNA,
and their alignment with the Sp6/HL chromosomal µ-
region is
indicated by the dashed lines in Fig. 1. The Cµ and C
homology
regions share a slight (63-bp) overlap between the SpeI and
XbaI sites located 3' of Cµ.

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 1.
Gene replacement at the chromosomal immunoglobulin
µ- locus. The structure of the haploid, chromosomal
immunoglobulin heavy chain µ- region in the recipient wild-type
mouse hybridoma cell line, Sp6/HL, is presented, along with this locus
in a recombinant hybridoma cell line generated as a result of gene
replacement with a single copy of the vector, pCµC pal. In
pCµC pal, endogenous restriction enzyme sites in the Cµ and C
regions (denoted in normal typeface) have been replaced with the
indicated genetic markers (denoted in bold typeface). The vector-borne
NotI site is contained within a perfect, 30-bp palindrome
insertion. In the Cµ region, marker positions are designated relative
to the Bst1107 site that defines the 5' end of this segment,
while the single marker position in the C region is numbered
relative to the SacI site that marks the 3' end of this
segment. For details relating to vector construction, refer to
Materials and Methods. Gene replacement has the potential to generate
different marker combinations in the various recombinant hybridoma cell
lines. Therefore, the five marker positions in the recombinant Cµ and
C regions are designated by a question mark. The primer pair
AB9703-AB9745 binds outside the Cµ region of homology in the
replacement vector and generates a specific 4.8-kb PCR product from the
recombinant Cµ region as shown. The sequence of the primers and where
they bind have been presented previously (17, 23). The
primer pair AB20191-AB20192 binds within the C region of homology
and generates a 0.8-kb product. The sequence of the C primers and
their binding sites are presented in Materials and Methods. Probe
fragments: Cµ-specific probe fragment F is an 870-bp
XbaI/BamHI fragment; probe X-R is a 913-bp
XhoI/EcoRI fragment from the C region.
Abbreviations: Cµ, µ gene constant region; C , gene constant
region; VHTNP, TNP-specific heavy-chain variable region;
neo, neomycin phosphotransferase gene. The thickened line
represents the vector, pSV2neo (28). The figure is not
drawn to scale.
|
|
The Cµ and C

homology regions bear specific genetic markers. The
Cµ region contains a 30-bp palindrome
(5'-GTACTGTATGT
GCGGCCGCACATACAGTAC-3')
inserted
into the endogenous
SacI,
AflII, and
ApaI sites at bp
557, 1117, and 1831. Palindrome insertion
replaces each endogenous
site with the novel
NotI site in
the palindrome (indicated in
boldface type in the sequence above). In
Fig.
1, the positions
of the vector-borne and chromosomal markers are
numbered relative
to the
Bst1107 site that marks the
beginning of the vector-borne
Cµ region according to the published
sequence (
4,
7). Originally,
the Cµ region genetic
markers were constructed for use in other
gene targeting vectors, and
the relevant details are presented
in Li and Baker (
16)
and Ng and Baker (
23). For this study,
standard molecular
cloning procedures (
27) were used to move
the markers into
the Cµ region of pCµC

pal. As a consequence of
the choice of
restriction enzyme sites used for subcloning, the
vector-borne Cµ
region also contained a
ScaI site replacing the
endogenous
NheI site at bp 2041. The C

region in pCµC

pal
contains
a single
NotI-palindrome genetic marker that
replaces the endogenous
PaeR71 site located 2,588 bp from
the C

terminus. For marker
insertion, the C

region was digested
with
PaeR71, and the cohesive
ends were ligated to the
following oligonucleotide
(5'-tcga
cGTACTGTATGT
GCGGCCGCACATACAGTAC
g-3').
The oligonucleotide contains the same 30-bp palindrome sequence
as indicated above (denoted in uppercase letters) with the embedded
diagnostic
NotI site (denoted in boldface type). To permit
ligation,
the oligonucleotide was synthesized with the terminal
nucleotides,
5'-tcga-3'. Nucleotides c and g (lowercase
underlined) were included
at the indicated positions to prevent
recreation of the endogenous
PaeR71 site. With the exception
of the inserted genetic markers,
the vector-borne Cµ and C

regions
were isogenic with the corresponding
chromosomal regions in the
recipient Sp6/HL hybridoma cell
line.
Vector transfer and isolation of independent G418R
transformants.
The pCµC
pal vector (8.7 pmol) was transferred
to 2 × 107 recipient Sp6/HL hybridoma cells by
electroporation as described elsewhere (1). Since the
enhancer-trap vector significantly reduces the frequency of random
transformants but not targeted recombinants (2, 22),
independent G418R transformants could be isolated according
to the plating procedure described previously (16, 23).
Recombinant identification and genetic marker analysis.
Genomic DNA was prepared from individual G418R
transformants by the method of Gross-Bellard et al. (8).
To identify recombinants, individual DNA samples were screened by a PCR
assay utilizing the primer pair AB9703-AB9745 that amplifies a specific
4.8-kb Cµ product from recombinant cells as illustrated in Fig. 1.
The primer sequences and their binding sites have been reported
elsewhere (17, 23). Hybridoma cell lines identified as
being recombinants were further characterized by Southern analysis to
verify the gene replacement event as detailed in Results. For Southern
analysis, restriction enzymes were purchased from New England Biolabs,
Inc. (Beverley, Mass.), Amersham Pharmacia Biotech, Inc. (Baie
d'Urfé, Québec, Canada), and Canadian Life Technologies,
Inc. (Burlington, Ontario, Canada) and used in accordance with the
manufacturer's specifications. Gel electrophoresis, transfer of DNA
onto nitrocellulose membrane, 32P-labeled probe
preparation, and hybridization were all performed according to standard
procedures (27).
For determination of the genetic markers residing in the Cµ region of
the recombinants, the specific 4.8-kb PCR product was
digested
separately with enzymes diagnostic of the various vector-borne
and
chromosomal markers. As described in Results, each enzyme
produces
diagnostic fragment sizes which can be resolved by standard
gel
electrophoresis, thus permitting genetic marker assignment
to the
correct positions. To determine whether the endogenous
PaeR71 site or the vector-borne palindrome
NotI
site resided in
the C

region, a combination of Southern and PCR
analysis was
used as explained in Results. The C

region PCR made use
of primer
AB20191 (5'-GAATAGAGCCTAGGAACTGG-3') that binds to
the coding
strand at C

genomic position bp 15566 and primer AB20192
(5'-CAGGTCCTCCTCTCAATGTA-3')
that binds to the noncoding
strand at C

genomic position bp 16413.
As shown in Fig.
1, this
primer pair generates an 848-bp product
that spans the
PaeR71/
NotI site and, as explained in the text
below, can be tested for resistance or sensitivity to cleavage
with
either
PaeR71 or
NotI.
 |
RESULTS |
Recombinant identification.
The purpose of this study was to
determine whether genetic markers form hDNA in a cis or a
trans configuration during mammalian gene replacement. The
gene targeting system is based on the wild-type hybridoma cell line,
Sp6/HL, which bears a single copy of the chromosomal immunoglobulin
µ-
region that serves as the target for homologous recombination
with the omega (
)-form of the enhancer-trap replacement vector,
pCµC
pal (Fig. 1). As reported previously (22, 23),
enhancer-trap vectors permit efficient isolation of targeted
recombinants at the chromosomal µ-
locus. The 4.2-kb Cµ
and 3.5-kb C
flanking arms of homology in pCµC
pal were
distinguishable from the corresponding regions of the chromosome at
several positions as a consequence of inclusion of a 30-bp palindrome
containing a unique NotI restriction enzyme site. The
palindrome genetic marker is poorly repaired by the mammalian MMR
system (16). Thus, following DNA replication and cell
division in a recombinant bearing unrepaired hDNA, a sectored (mixed)
recombinant is generated. A plating (sectoring) assay was used to
recover independent recombinants. As described previously (16,
23), the procedure ensures that each recombinant represents the
progeny of a single G418R cell and that the
G418R product(s) of recombination is retained for molecular analysis.
Two separate vector transfers were performed. In each, 8.7 pmol of
pCµC

pal was introduced into 2 × 10
7 recipient
Sp6/HL hybridoma cells by electroporation as described
earlier
(
1). Within 1 h following electroporation, 0.1-ml
aliquots
of the culture, each containing ~6,000 hybridoma cells, were
distributed
to 3,333 individual wells of 96-well tissue culture plates.
Trypan
blue staining revealed that, on average, ~50% of the
hybridoma
cells survived electroporation. Therefore, each culture well
received
~3,000 viable hybridoma cells. After G418 selection, the
number
of G418
R transformants was recorded. A total of 281 independent G418
R transformants were generated from the
~2 × 10
7 cells surviving electroporation in the two
experiments, giving
a transformation frequency of ~1.4 × 10
5 G418
R transformants/cell. Genomic DNA was
prepared from 217 independent
G418
R transformants and
screened by PCR using primer pair AB9703-AB9745
for the specific 4.8-kb
Cµ region product predicted by the gene
replacement reaction (Fig.
1). This screening identified 12 and
16 hybridoma cell lines from the
first and second electroporations,
respectively, that bore the 4.8-kb
Cµ region PCR product. No PCR
product was evident in the remaining
189 G418
R transformants, suggesting that the endogenous
µ-

region was
not targeted (data not
shown).
The 28 independent hybridoma cell lines were further characterized by
Southern analysis to confirm the gene replacement event.
As shown in
Fig.
1, linkage of vector-borne and chromosomal sequences
is expected
to replace the endogenous Sp6/HL 19.0-kb
ScaI fragment
with
ScaI fragments of 11.9 and 12.6 kb detected with probe
fragments
F and X-R, respectively. In the event, the chromosomal
NheI and
vector-borne
ScaI Cµ region sites are
encompassed within hDNA
and the mismatch repaired to the
ScaI site, the 11.9-kb
ScaI fragment
detected
with probe F will be replaced with a 9.1-kb
ScaI fragment
as
shown. These digests revealed that 26 of the 28 hybridoma cell
lines
contained the expected
ScaI fragment sizes (data not shown).
In one of the 26 cell lines (recombinant 34/2), in addition to
the
expected fragment sizes, additional
ScaI fragments
consisting
of the endogenous 19.0-kb µ-

region and a novel 15.5-kb
fragment
were also visible. This suggested that hybridoma cell line
34/2
might actually be derived from two cells; one cell in which the
endogenous µ-

region is targeted and a second cell in which the
replacement vector has integrated randomly in the genome and where
the
endogenous µ-

region is unaltered. As described below, this
interpretation was verified following analysis of hybridoma 34/2
subclones. The fragment sizes observed in 2 of the 28 hybridoma
cell
lines (37/1 and 8/2) did not fit the expected pattern entirely
and are
still under
investigation.
In summary, of the 28 hybridoma cell lines identified by PCR screening,
26 (or ~12% of the total G418
R transformants analyzed)
were verified by Southern analysis as
being correct gene replacement
events. When expressed as a frequency
of the number of hybridoma cells
surviving electroporation, the
absolute mean frequency of gene
replacement was 1.8 × 10
6 G418
R
recombinants/cell. Since the recovery of recombinants among the
6,666 wells plated in the two electroporations is expected to
follow the
Poisson distribution, the probability that any of the
G418
R
recombinants actually derived from more than one independent
recombinant is ~0.002.
Genetic marker determination.
For determination of the Cµ
region genetic markers, the 4.8-kb PCR product was tested for its
resistance or sensitivity to cleavage with restriction enzymes specific
for the vector-borne markers, namely, NotI and
ScaI, or the corresponding enzymes specific for chromosomal
markers, namely, SacI, AflII, ApaI,
and NheI (Fig. 1). As shown in Fig.
2A, the various restriction enzymes
generate diagnostic Cµ fragment sizes that can be conveniently
analyzed by agarose gel electrophoresis. To determine which genetic
marker resided in the C
region of each recombinant, Southern
analysis was utilized. As illustrated in Fig. 2B, digestion of genomic DNA with the HpaI-NotI combination and, in a
separate digest, the combination of HpaI and
PaeR71 followed by hybridization with probe X-R
distinguishes whether the C
marker is the vector-borne NotI palindrome or the corresponding endogenous
PaeR71 site.

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 2.
Restriction enzyme maps of the Cµ and C region in
the recombinants. (A) Diagram of the 4.8-kb PCR product generated
from the recombinant Cµ region using primer pair AB9703-AB9745 and
the fragment sizes expected if the indicated positions bear either the
vector-borne or chromosomal restriction enzyme site markers. (B)
Illustration of the Southern blot analysis used to resolve whether the
vector-borne palindrome NotI site or chromosomal
PaeR71 site resides in the C region. Vector-borne markers
are denoted in bold typeface. The diagrams are not drawn to scale.
|
|
As an example of this analysis, Fig.
3A and
B present the determination of the Cµ
and C

region markers, respectively, for
recombinants 4/1, 7/1, and
8/1. With respect to the Cµ region
(Fig.
3A), in recombinant 7/1, a
single 4.8-kb fragment was visible
following
NotI digestion.
This is the expected size for the undigested
PCR product, indicating
the absence of
NotI sites in the Cµ region
of this
recombinant. However, the Cµ region PCR product was sensitive
to
cleavage with
SacI,
AflII, and
ApaI
producing the expected
fragment sizes in each case. The Cµ region
from recombinant 7/1
was also completely sensitive to digestion with
NheI, producing
the expected 2.2- and 2.6-kb fragments (Fig.
2A) but was resistant
to cleavage with
ScaI, as evidenced by
the presence of the uncut
4.8-kb PCR product. Thus, recombinant 7/1
contains the endogenous
SacI,
AflII,
ApaI, and
NheI sites in the Cµ region. In
contrast,
the Cµ region in recombinants 4/1 and 8/1 was partially
sensitive
to digestion with the
SacI,
AflII, and
ApaI enzymes diagnostic
of the chromosomal markers, as well
as
NotI specific for the vector-borne
palindrome marker, as
evidenced by the presence of the expected
cleavage products for each
enzyme tested as well as residual,
uncut 4.8-kb fragment. When the Cµ
region PCR product of both
recombinants was digested separately with
NheI and
ScaI, the results
revealed complete
cleavage with
ScaI. Thus, recombinants 4/1 and
8/1 both bear
the
ScaI marker at Cµ position bp 2041 but are
heterogeneous
for the remaining Cµ marker positions.


View larger version (94K):
[in this window]
[in a new window]
|
FIG. 3.
Analysis of Cµ and C region marker patterns in
recombinants 4/1, 7/1, and 8/1. The results in panels A and B
present the analysis of the Cµ and C region genetic markers,
respectively, in recombinants 4/1, 7/1, and 8/1. The sizes of fragments
of interest are presented on the left of each figure, while the sizes
of relevant DNA marker bands (denoted M) are presented on the right.
|
|
With respect to the C

region (Fig.
3B), Southern analysis of genomic
DNA from recombinant 4/1 digested with the combination
HpaI-
NotI and hybridized with probe X-R revealed
the 14.3-kb fragment.
When this DNA was digested with
HpaI-
PaeR71, only the uncut 16.1-kb
fragment was
visible. Therefore, recombinant 4/1 bears the
NotI-palindrome
at this site in the C

region. In
contrast,
HpaI/
NotI-digested
genomic DNA from
recombinants 7/1 and 8/1 revealed both 14.3-
and 16.1-kb fragments. The
14.3-kb fragment indicates that a portion
of the DNA contains the
NotI palindrome at the expected position,
while the
continued presence of the 16.1-kb fragment reveals that,
in the
remaining DNA, the
NotI site is absent. This suggests that
these recombinants are heterogeneous at this C

marker position,
and
this was confirmed following digestion with the combination
HpaI-
PaeR71. Here, a portion of the DNA is
sensitive to cleavage
with
PaeR71, generating the 14.3-kb
fragment, while the remaining
DNA is insensitive to cleavage with this
enzyme, yielding the
16.1-kb fragment (Fig.
3A).
The same analysis was performed on each of the remaining recombinants
(data not shown), and the results are summarized in
Fig.
4. Recombinants identified from the two
separate electroporations
are indicated by the coding
n/1 or
n/2, respectively. In a single
recombinant (29/2), neither
the vector-borne
NotI-palindrome nor
the chromosomal
PaeR71 marker was present in the C

region, suggesting
mutation of this site (as indicated by the cross-hatched circle).
In
the event this was a deletion, it must have been small because
the C

region
ScaI fragment in this recombinant was of the expected
size of 12.6 kb (data not shown).

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 4.
Marker segregation patterns in independent
recombinants. The results of the Cµ and C region marker
analysis for the recombinants are presented. The symbols used to denote
the various genetic markers are explained in the text. The results of
subcloning analysis of recombinants displaying >1 sectored site, along
with the observed frequencies of the individual cell types, are
presented in brackets. In the diagrams, the pSV2neo sequences
separating the Cµ and C regions are denoted as neo.
Positions bearing the vector-borne NotI-palindrome are
indicated by a filled circle ( ); those with a chromosomal marker are
indicated by an open circle ( ), while those sites that are sensitive
to clevage with restriction enzymes diagnostic of both the chromosome
and vector-borne markers (i.e., heterogeneous sites) are indicated by
half-filled circles ( ). The cross-hatched circle with recombinant
29/2 indicates that neither the vector-borne NotI-palindrome
nor the chromosomal PaeR71 marker was present in the
C region.
|
|
Clonal analysis of sectored recombinants.
As described above,
the recombinant isolation procedure ensures that the individual
product(s) of each gene replacement event is confined to a single
culture well. Consequently, the marker configurations in the cell
populations comprising each sectored recombinant reflect those present
in each strand of the hDNA intermediate. As is evident from Fig. 4,
recombinants 4/1, 8/1, 27/1, 29/1, 11/2, 22/2, 14/2, 16/2, 34/2, 36/2,
42/2, and 59/2 were sectored for more than one position in the Cµ
and/or C
region. Therefore, for these recombinants, it was necessary
to establish marker linkage. This was accomplished by cloning each
recombinant at 0.1 cell/well in 96-well tissue culture plates and
repeating the Cµ and C
marker determinations on several
independent subclones (data not shown). As for the parental
recombinants, PCR and gel analysis methods were used to determine the
Cµ region markers in the subclones. For the C
region, Southern
blotting was utilized as described above. In addition, a more
convenient PCR-gel analysis assay was developed. As illustrated in Fig.
1, the primer pair AB20192-AB20191 lies within the vector-borne (and
chromosomal) C
region of homology. These primers amplify a specific
848-bp PCR product that spans the potential mismatch created by the
endogenous PaeR71 and vector-borne NotI-palindrome markers. If either PaeR71 or
NotI sites are present in the recombinants, the PCR product
will be cleaved to yield diagnostic fragments of 644 and 203 bp. Using
these procedures, the C
region marker patterns in the subclones of
the various parental recombinants was determined. Equivalent results
were obtained with either Southern or PCR assays. The parental
recombinants, the subclone marker patterns, and the frequency of the
various subclone types are presented in brackets in Fig. 4.
Subclones of recombinants 4/1, 14/2, and 59/2 contained either the
vector-borne
NotI-palindrome or the corresponding
chromosomal
marker at those Cµ region positions that were originally
sectored
as expected for replication and cell division of a hDNA
intermediate.
In recombinants 8/1, 27/1, 29/1, 11/2, 22/2, 16/2, 34/2,
36/2,
and 42/2, the sectored sites resided in both the Cµ and the
C
regions and the marker linkage was of particular interest. For
all
recombinants except 8/1, the markers associated with the sectored
sites
resided in a
trans configuration. That is, in one population
of cells, the vector-borne
NotI marker in a Cµ region
position(s)
was linked to the chromosomal
PaeR71 site in the
C

region, while
in the other cell population, the vector-borne
NotI marker in
the C

region was linked to a chromosomal
marker(s) in the Cµ
region. In the single exception (recombinant 8/1)
the markers
in the sectored sites were linked in a
cis
configuration. The
significance of the marker linkage pattern in these
recombinants
will be explained in the
Discussion.
Southern analysis suggested that recombinant 34/2 may have been derived
from two cells, one cell in which a targeted gene
replacement has
occurred and a second cell in which the replacement
vector has
integrated randomly. The subcloning results support
this interpretation
with the evidence as follows. As for the other
recombinants, in the
single cell undergoing gene replacement,
hDNA was formed but not
repaired. Thus, following DNA replication
and cell division, two cell
populations were generated in which
the Cµ and C

markers were in a
trans configuration in the proportions
indicated in Fig.
4.
The presence of a second cell with an unmodified
endogenous µ-

region and a random vector integration was revealed
during subcloning
analysis as a third population of cells comprising
6 of the 11 subclones studied. In these cells, the Cµ region could
not be
amplified with primer pair AB9703-AB9745, a result expected
if gene
replacement had not occurred (Fig.
1). Random vector integration
was
revealed by production of the 848-bp C

region PCR product
with
primers AB20192 and AB20191 and by its sensitivity to cleavage
with
both
NotI (expected for the randomly integrated vector) and
PaeR71 (expected for the unmodified endogenous
locus).
In a few of the parental recombinants, the frequency of subclone types
appeared to deviate somewhat from the equivalence expected
for
replication of the hDNA intermediate (Fig.
4). Likely reasons
for this
include the small subclone sample size and, perhaps,
the loss of some
progeny during expansion of the single recombinant
cell rather than to
any difference between these recombinants
and the others with respect
to the mechanism of gene
replacement.
Evidence for extensive hDNA formation and of MMR during gene
replacement.
The positions of sectored sites revealed that hDNA
formation during mammalian gene replacement was extensive (Fig. 4). In recombinants 4/1, 8/1, and 14/2, all positions up to and including the
ApaI/NotI-palindrome mismatch located 1,831 bp
from the beginning of the Cµ region were sectored, suggesting that
hDNA had formed over this distance. In recombinants 5/1, 7/1, 20/1, and
several others, the PaeR71/NotI-palindrome
mismatch located 2,588 bp from the C
terminus was sectored,
suggesting that a long hDNA tract had spanned this region. Also, as
indicated in the previous section, sectoring was observed for internal
markers in both the Cµ and C
region of several recombinants. These
results indicate that in mammalian cells long regions of hDNA are
formed in both flanking arms of homology in the replacement vector.
Several examples of repair of mismatches involving the palindrome were
evident. In recombinants 11/2, 22/2, and 36/2, sectoring
was observed
at Cµ marker positions bp 557 and bp 1831 with the
internal marker at
position bp 1117 being converted to the chromosomal
AflII
site (recombinants 11/2 and 22/2) or restored to the vector-borne
NotI site in recombinant 36/2). In recombinants 27/1, 29/1,
and
29/2, a sectored site(s) in the Cµ region was preceded by the
vector-borne
NotI palindrome marker. This suggested that an
hDNA
tract spanning at least these marker positions was subject to
MMR
generating the observed restoration events. In recombinants
34/2, 42/2,
and 64/2 a sectored site was followed by a chromosomal
marker,
suggesting that the original hDNA tract spanning at least
these sites
was partially converted. In recombinant 48/1, the
hDNA tract must have
spanned at a minimum the first two Cµ markers
with MMR generating the
gene conversion at position bp 1117. Finally,
in recombinant 40/2, the
hDNA tract spanned at least the last
two Cµ markers at positions bp
1831 and 2041, with the mismatch
at the latter site undergoing gene
conversion. During the various
subcloning steps that were involved in
constructing pCµC

pal,
the Cµ region of homology in the vector
also contained an additional
polymorphism, a simple 4-bp insertion loop
that created a
ScaI
site in place of the endogenous
NheI site at position (2041 bp).
In contrast to mismatches
involving the palindrome, sectoring
at the
ScaI/
NheI polymorphism was never observed. If
this site
was encompassed within hDNA, as suggested by the data above,
then
the lack of sectoring is not surprising since our studies have
shown that these simple mismatches are usually well repaired prior
to
DNA replication (
23).
As is evident from examination of Fig.
4, of the total of 130 Cµ and
C

marker positions, 50 of 130 bore a chromosomal marker,
36 of 130 bore the vector-borne
NotI palindrome marker and, with
the
exception of the single C

site in recombinant 29/2 where
there was
no marker, the remaining 43 of the 130 sites were sectored.
Of the
total of 86 sites that bore either a chromosomal or vector-borne
marker, the slightly higher frequency of sites bearing a chromosomal
marker was not significantly different according to a
2
test (
P = 0.13).
 |
DISCUSSION |
Eight recombinants (8/1, 27/1, 29/1, 11/2, 22/2, 16/2, 34/2, 36/2,
and 42/2) were sectored in both flanking arms of homology. Genetic
marker analysis in subclones derived from each recombinant revealed
that in seven (27/1, 29/1, 11/2, 22/2, 16/2, 34/2, 36/2, and 42/2),
vector-borne and chromosomal markers in the two homology regions were
linked in a trans configuration. The trans
configuration of markers in hDNA is inconsistent with assimilation of a
single strand of the vector into the chromosome but, rather, strongly supports a mechanism of gene replacement in mammalian cells that involves two crossing-over events in homologous flanking DNA. A
proposed model is presented in Fig. 5.
Essentially, this model is the alternative to the single-strand
assimilation model as presented in Fig. 3C of a study by Leung et al.
(15). Recombination initiates when the two ends of
the vector invade the chromosome and pair with their complementary
sequences. For simplicity, invasion by single-stranded (perhaps,
3') ends of opposite DNA strands is shown (30). An
alternative, unconventional model might involve invasion of both ends
of the same vector strand. Our data do not permit this distinction to
be made. In either case, Holliday junction branch migration results in
the formation of extensive hDNA in both flanking regions of homology.
The entire vector is incorporated into the chromosome by crossover
resolution of the two Holliday junctions as a consequence of cutting
the DNA strands at positions numbered 1, 4, and 5 and positions number
2, 3, and 6 as indicated. Following strand ligation, genetic markers
form hDNA in the trans configuration. The cis
configuration of hDNA in the single recombinant (8/1) can also be
explained if cuts in the DNA strands are made at the alternate
positions of 1 and 6' and of 2, 3, 4', and 5' as shown in the figure.
Thus, this simple model readily accounts for the generation of the
recombinants. Notable features include pairing between complementary
strands of the vector and the chromosomal target, the formation of long
regions of hDNA, and the requirement for resolution of two Holliday
junctions for vector incorporation into the chromosome. Thus, in these
respects the model bears resemblance to the DSBR mechanism of
recombination (24, 32), a model that appears consistent
with targeted vector insertion in mammalian cells (16, 17, 23,
34).

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 5.
Proposed model for mammalian gene replacement.
Recombination is depicted as initiating when different DNA strands from
the two homologous arms of the vector invade the chromosome. Gene
replacement results from crossing-over in each flanking arm and is
accompanied by extensive formation of hDNA. For further mechanistic
details, refer to the text.
|
|
The finding that mammalian gene replacement occurs by two crossing-over
events is of importance in view of current models of gene replacement
in yeast in which strand assimilation leading to gene conversion is
proposed to occur predominantly (15). In fact, based on
the yeast studies, it was suggested that the preferential repair of
hDNA in favor of the chromosome might frequently eliminate vector-borne
heterologies, including the selectable genetic marker, and thus
constitute an efficient barrier to recombination with the
-form gene replacement vectors in mammalian cells
(15). Thus, the yeast data predict that gene replacement
with a linear fragment of DNA contiguous with the chromosome should be
much more efficient than that with a replacement vector. Thus, it was surprising that, in our previous study (18), we observed
that gene targeting with a linear genomic fragment was only slightly more efficient (~2-fold) than with an
-form replacement
vector bearing a similar amount of overall homology. The above data
suggest that the mammalian gene replacement reaction is not frequently overcome by the cellular MMR machinery. In support of this, a biased
elimination of vector-borne markers as a consequence of MMR was not
clearly evident in this or our previous gene targeting studies
(18, 23). Also, there was no evidence that inclusion of
genetic markers in the vector-borne homology regions reduced the
efficiency of gene targeting compared to vectors bearing a completely
wild-type, isogenic sequence (18, 23). The differences between yeast and mammalian cells can be reconciled if, as suggested by
this study, mammalian cells mediate the gene replacement reaction primarily by two crossing-over events. Thus, in contrast to yeast, a
factor(s) other than biased action of the cell's MMR machinery may be
responsible for the low efficiency of gene targeting relative to random
integration in the mammalian genome.
The gene replacement mechanism in Fig. 5 depends on the two ends of the
replacement vector locating the correct target sequence and undergoing
strand invasion. Since the vector ends point away from each other,
there would appear to be a requirement for them to behave independently
for this to be accomplished. Therefore, strand invasion may be an
efficient process in mammalian gene targeting. In contrast, strand
invasion may be inherently inefficient in yeast, as suggested
previously (15). Thus, it would be unlikely that both ends
of a linear fragment would independently engage the target sequence and
undergo strand invasion before strand assimilation from one end spans
the entire fragment.
In the gene replacement vector used in this study, the vector ends were
completely homologous to the chromosomal target, a feature which
presumably made the strand invasion step relatively straightforward.
This is not always the case as replacement vectors designed for use in
positive-negative selection (PNS) schemes (19) terminate
in heterologous sequences that encode a counterselectable marker(s)
(for example, the herpes simplex virus thymidine kinase gene).
Therefore, in order for these vector designs to undergo correct gene
replacement, the terminal nonhomology must be removed. In S. cerevisiae, removal of nonhomologous DNA ends during recombination depends on the activity of the nucleotide excision repair endonuclease Rad1 or Rad10 and also on the mismatch repair proteins Msh2 and Msh3
(25, 29). In mammalian cells, equivalent proteins acting in the same manner may fulfill this role. Terminal nonhomology may be
removed prior to any homologous pairing, thus creating homologous ends
that can undergo strand invasion. However, it is also possible that
pairing between homologous vector-borne and chromosomal sequences
occurs first between more internal sequences in each flanking arm with
subsequent removal of the terminal "flaps" and resynthesis, as
suggested by the ectopic recombination data of Inbar and Kupiec
(12).
The positions of sectored sites in several recombinants provided strong
evidence for extensive formation of hDNA in both flanking arms of
homology during mammalian gene replacement. This observation is novel
and pertinent to the model presented in Fig. 5. Long hDNA tracts as
revealed by the positions of sectored sites generated by failure to
repair mismatches involving the palindrome have also been reported for
targeted vector insertion in mammalian cells (16). The
formation of long hDNA tracts during mammalian gene targeting provides
a conceptual basis for the gene conversion tracts reported previously
by us (18, 23) and others (5, 6, 11) which
were suggested to have resulted from MMR of hDNA. Similarly, in the
present study, the results suggested that some mismatches in hDNA were
also subject to repair undergoing either restoration or gene
conversion. However, in some cases, there are difficulties in
distinguishing MMR of hDNA from other possible explanations. For
example, although MMR of hDNA provides an explanation for the presence
of vector-borne markers in proximity to the pSV2neo sequences such as
in recombinants 3/1, 4/1, 8/1, 16/1, and others, they are also
consistent with the possibility of a crossover event in the Cµ region
just prior to the markers. Another example is the presence of
chromosomal markers in the Cµ region of several recombinants (3/1,
5/1, 7/1, 20/1, and others), a pattern that, while consistent with gene
conversion resulting from MMR of hDNA, might also result from deletion
of vector sequences from the ends of the transferred DNA followed by
their replacement with chromosomal sequences. While several studies in
mammalian cells have suggested that, in general, degradation from the
ends of transfected DNA is probably not extensive (6, 10, 12, 16,
23, 26, 27, 30), studies in yeast show that there can be
extensive 5'-3' exonucleolytic resection of 5'-ending strands to expose
long single-stranded regions (9, 30). If such extensive resection is a component of the mammalian gene replacement reaction, it
would support the two-stranded invasion model of gene replacement depicted in Fig. 5 and may contribute substantially to the conversion and/or restoration events observed in the recombinants.
 |
ACKNOWLEDGMENTS |
This work was supported by an operating grant from the Canadian
Institutes of Health Research (CIHR) (MOP-14416) to M.D.B. and a CIHR
Post-Doctoral Fellowship award to J.L.
We thank Steven Raynard, Patricia Bell, and Richard McCulloch, members
of our laboratory, for their helpful comments during the course of this
work. We thank Erin Wever for excellent technical assistance.
 |
FOOTNOTES |
*
Corresponding author. Present address: Department of
Animal and Poultry Science, Ontario Agricultural College, University of
Guelph, Guelph, Ontario, Canada N1G 2W1. Phone: (519) 824-4120, ext.
2713. E-mail: jli{at}uoguelph.ca.
 |
REFERENCES |
| 1.
|
Baker, M. D.,
N. Pennell,
L. Bosnoyan, and M. J. Shulman.
1988.
Homologous recombination can restore normal immunoglobulin production in a mutant hybridoma cell line.
Proc. Natl. Acad. Sci. USA
85:6432-6436[Abstract/Free Full Text].
|
| 2.
|
Bautista, D., and M. J. Shulman.
1993.
A hit-and-run system for introducing mutations into the immunoglobulin heavy chain locus of hybridoma cells by homologous recombination.
J. Immunol.
151:1950-1958[Abstract].
|
| 3.
|
Bertling, W. M.
1995.
Gene targeting, p. 1-44.
In
M. A. Vega (ed.), Gene targeting. CRC Press, Inc., Boca Raton, Fla.
|
| 4.
|
Bilofsky, H. S.,
C. Burks,
J. W. Fickett,
W. B. Goad,
F. I. Lewitter,
W. P. Rindone,
C. D. Swindell, and C.-S. Tung.
1986.
The Gen-Bank® genetic sequence databank.
Nucleic Acids Res.
14:1-4[Abstract/Free Full Text].
|
| 5.
|
Donoho, C.,
M. Jasin, and P. Berg.
1998.
Analysis of gene targeting and intrachromosomal homologous recombination stimulated by genomic double-strand breaks in mouse embryonic stem cells.
Mol. Cell. Biol.
18:4070-4078[Abstract/Free Full Text].
|
| 6.
|
Elliot, B.,
C. Richardson,
J. Winderbaum,
J. A. Nickoloff, and M. Jasin.
1998.
Gene conversion tracts from double-strand break repair in mammalian cells.
Mol. Cell. Biol.
18:93-101[Abstract/Free Full Text].
|
| 7.
|
Goldberg, G. I.,
E. F. Vanin,
A. M. Zrolka, and F. R. Blattner.
1981.
Sequence of the gene for the constant region of the µ chain of Balb/c mouse.
Gene
15:33-42[CrossRef][Medline].
|
| 8.
|
Gross-Bellard, M.,
P. Qudet, and P. Chambon.
1973.
Isolation of high-molecular weight DNA from mammalian cells.
Eur. J. Biochem.
36:32-38[Medline].
|
| 9.
|
Haber, J.
1995.
In vivo biochemistry: physical monitoring of recombination induced by site-specific endonucleases.
Bioessays
17:609-620[CrossRef][Medline].
|
| 10.
|
Hastings, P. J.,
C. McGill,
B. Shafer, and J. N. Strathern.
1993.
Ends-in vs. ends-out recombination in yeast.
Genetics
135:973-980[Abstract].
|
| 11.
|
Hasty, P.,
J. Rivera-Perez, and A. Bradley.
1995.
Gene conversion during vector insertion in embryonic stem cells.
Mol. Cell. Biol.
12:2464-2474[Abstract/Free Full Text].
|
| 12.
|
Inbar, O., and M. Kupiec.
1999.
Homology search and choice of homologous partner during mitotic recombination.
Mol. Cell. Biol.
19:4134-4142[Abstract/Free Full Text].
|
| 13.
|
Köhler, G.,
M. J. Potash,
H. Lehrach, and M. J. Shulman.
1982.
Deletions in immunoglobulin mu chains.
EMBO J.
1:555-563[Medline].
|
| 14.
|
Köhler, G., and M. J. Shulman.
1980.
Immunoglobulin M mutants.
Eur. J. Immunol.
10:467-476.
|
| 15.
|
Leung, W.-Y.,
A. Malkova, and J. E. Haber.
1997.
Gene targeting by linear duplex DNA frequently occurs by assimilation of a single strand that is subject to preferential mismatch correction.
Proc. Natl. Acad. Sci. USA
94:6851-6856[Abstract/Free Full Text].
|
| 16.
|
Li, J., and M. D. Baker.
2000.
Use of a small palindrome genetic marker to investigate mechanisms of double-strand-break repair in mammalian cells.
Genetics
154:1281-1289[Abstract/Free Full Text].
|
| 17.
|
Li, J., and M. D. Baker.
2000.
Formation and repair of heteroduplex DNA on both sides of the double-strand break during mammalian gene targeting.
J. Mol. Biol.
295:505-516[CrossRef][Medline].
|
| 18.
|
Li, J., and M. D. Baker.
2000.
Mechanisms involved in targeted gene replacement in mammalian cells.
Genetics
156:809-821[Abstract/Free Full Text].
|
| 19.
|
Mansour, S. L.,
K. R. Thomas, and M. R. Capecchi.
1988.
Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes.
Nature
336:348-352[CrossRef][Medline].
|
| 20.
|
Nag, D. K.,
M. A. White, and T. D. Petes.
1989.
Palindromic sequences in heteroduplex DNA inhibit mismatch repair in yeast.
Nature
340:318-320[CrossRef][Medline].
|
| 21.
|
Negritto, M. T.,
X. Wu,
T. Kuo,
S. Chu, and A. M. Bailis.
1997.
Influence of DNA sequence identity on efficiency of targeted gene replacement.
Mol. Cell. Biol.
17:278-286[Abstract].
|
| 22.
|
Ng, P., and M. D. Baker.
1998.
High efficiency, site-specific modification of the chromosomal immunoglobulin locus by gene targeting.
J. Immunol. Methods
214:81-96[CrossRef][Medline].
|
| 23.
|
Ng, P., and M. D. Baker.
1999.
Mechanisms of double-strand-break repair during gene targeting in mammalian cells.
Genetics
151:1127-1141[Abstract/Free Full Text].
|
| 24.
|
Orr-Weaver, T. L.,
J. W. Szostak, and R. J. Rothstein.
1981.
Yeast transformation: a model system for the study of recombination.
Proc. Natl. Acad. Sci. USA
78:6354-6358[Abstract/Free Full Text].
|
| 25.
|
Pâques, F., and J. E. Haber.
1997.
Two pathways for removal of nonhomologous DNA ends during double-strand break repair in Saccharomyces cerevisiae.
Mol. Cell. Biol.
17:6765-6771[Abstract].
|
| 26.
|
Rothstein, R.
1983.
One-step gene disruption in yeast.
Methods Enzymol.
101:202-211[Medline].
|
| 27.
|
Sambrook, J.,
E. F. Fritsch,
E. F., and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
|
| 28.
|
Southern, P. J., and P. Berg.
1981.
Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter.
J. Appl. Mol. Genet.
1:327-341.
|
| 29.
|
Sugawara, N.,
F. Pâques,
M. Colaiacovo, and J. E. Haber.
1997.
Role of Msh2 and Msh3 repair proteins in double-strand break induced recombination.
Proc. Natl. Acad. Sci. USA
94:9214-9219[Abstract/Free Full Text].
|
| 30.
|
Sun, H.,
D. Treco, and J. W. Szostak.
1991.
Extensive 3'-overhanging, single-stranded DNA associated with meiosis-specific double strand breaks at the ARG4 recombination initiation site.
Cell
64:1155-1161[CrossRef][Medline].
|
| 31.
|
Surosky, R. T., and B. K. Tye.
1987.
Site-directed chromosomal rearrangements in yeast.
Methods Enzymol.
153:243-253[Medline].
|
| 32.
|
Szostak, J. W.,
T. L. Orr-Weaver,
R. J. Rothstein, and F. W. Stahl.
1983.
The double-strand-break repair model for recombination.
Cell
33:25-35[CrossRef][Medline].
|
| 33.
|
Waldman, A. S.
1992.
Targeted homologous recombination in mammalian cells.
Crit. Rev. Oncol. Hematol.
12:49-64[Medline].
|
| 34.
|
Valancius, V., and O. Smithies.
1991.
Double-strand gap repair in a mammalian gene targeting reaction.
Mol. Cell. Biol.
11:4389-4397[Abstract/Free Full Text].
|
| 35.
|
Vega, M. A.
1995.
Gene targeting in human gene therapy, p. 211-229.
In
M. A. Vega (ed.), Gene targeting. CRC Press, Inc., Boca Raton, Fla.
|
Molecular and Cellular Biology, January 2001, p. 501-510, Vol. 21, No. 2
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.2.501-510.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Johzuka-Hisatomi, Y., Terada, R., Iida, S.
(2008). Efficient transfer of base changes from a vector to the rice genome by homologous recombination: involvement of heteroduplex formation and mismatch correction. Nucleic Acids Res
36: 4727-4735
[Abstract]
[Full Text]
-
Neuwirth, E. A. H., Honma, M., Grosovsky, A. J.
(2007). Interchromosomal Crossover in Human Cells Is Associated with Long Gene Conversion Tracts. Mol. Cell. Biol.
27: 5261-5274
[Abstract]
[Full Text]
-
Barnes, R. L., McCulloch, R.
(2007). Trypanosoma brucei homologous recombination is dependent on substrate length and homology, though displays a differential dependence on mismatch repair as substrate length decreases. Nucleic Acids Res
35: 3478-3493
[Abstract]
[Full Text]
-
Langston, L. D., Symington, L. S.
(2004). Gene targeting in yeast is initiated by two independent strand invasions. Proc. Natl. Acad. Sci. USA
101: 15392-15397
[Abstract]
[Full Text]
-
Read, L. R., Raynard, S. J., Ruksc, A., Baker, M. D.
(2004). Gene repeat expansion and contraction by spontaneous intrachromosomal homologous recombination in mammalian cells. Nucleic Acids Res
32: 1184-1196
[Abstract]
[Full Text]
-
McCulloch, R. D., Read, L. R., Baker, M. D.
(2003). Strand Invasion and DNA Synthesis From the Two 3' Ends of a Double-Strand Break in Mammalian Cells. Genetics
163: 1439-1447
[Abstract]
[Full Text]
-
Musikacharoen, T., Yoshikai, Y., Matsuguchi, T.
(2003). Histone Acetylation and Activation of cAMP-response Element-binding Protein Regulate Transcriptional Activation of MKP-M in Lipopolysaccharide-stimulated Macrophages. J. Biol. Chem.
278: 9167-9175
[Abstract]
[Full Text]
-
Elliott, B., Jasin, M.
(2001). Repair of Double-Strand Breaks by Homologous Recombination in Mismatch Repair-Defective Mammalian Cells. Mol. Cell. Biol.
21: 2671-2682
[Abstract]
[Full Text]